
Topical vancomycin: Does it reduce surgical site infection in bone tumors?
Author(s) -
Suman Byregowda,
Ajay Puri,
Ashish Gulia
Publication year - 2017
Publication title -
south asian journal of cancer
Language(s) - English
Resource type - Journals
eISSN - 2278-4306
pISSN - 2278-330X
DOI - 10.4103/2278-330x.214572
Subject(s) - medicine , vancomycin , perioperative , surgery , incidence (geometry) , intramedullary rod , pelvis , group b , antibiotics , staphylococcus aureus , physics , microbiology and biotechnology , biology , bacteria , optics , genetics
We retrospectively analyzed a consecutive group of patients operated for bone tumors of extremity and pelvis who received only perioperative antibiotics (Group A) against a similar group that had additional 1 g topical vancomycin sprinkled in the wound before closure (Group B). The aim was to determine if the addition of topical vancomycin decreases the incidence of deep surgical site infection (SSI).